Management of multiple myeloma in older adults: Gaining ground with geriatric assessment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of multiple myeloma in older adults: Gaining ground with geriatric assessment

Published:2017-01 Issue:1 Volume:8 Page:1-7
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Wildes Tanya M.,Campagnaro Erica^ORCID

Funder

National Cancer Institute (NCI)

National Institutes of Health (NIH)

Clinical and Translational Science Award (CTSA)

National Center for Advancing Translational Sciences (NCATS)

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference73 articles.

1. Future distribution of multiple myeloma in the United States by sex, age, and race/ethnicity;Rosenberg;Blood,2015

2. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients;Kumar;Leukemia,2014

3. Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials;Bringhen;Haematologica,2013

4. Bortezomib–melphalan–prednisone–thalidomide followed by maintenance with bortezomib–thalidomide compared with bortezomib–melphalan–prednisone for initial treatment of multiple myeloma: a randomized controlled trial;Palumbo;J Clin Oncol,2010

5. Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75years: a population-based analysis;Pozzi;Br J Haematol,2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Strategies and Future Directions in Multiple Myeloma: Disease Overview and Pathophysiology, Conventional Treatments and Emerging Therapies, Challenges and Innovations in Management;European Journal of Medical and Health Research;2024-09-01

2. Hematologic Malignancies;Geriatric Medicine;2024

3. Hematologic Malignancies;Geriatric Medicine;2023

4. Patient characteristics associated with dose modifications for VRd among newly diagnosed multiple myeloma patients;Future Oncology;2022-11

5. Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematologica Pugliese’;Annals of Hematology;2022-05-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3